Applications published 19 September 2007

Published: 1-Sep-2008


Pharmaceutical formulations
Schering 1833461*

Pharmaceutical manufacturing process for heat sterilised glucocorticoid suspensions
Norton Healthcare 1833462*

Process for milling poorly soluble drugs in the presence of liquid propellants
Glaxo Group 1833463*

Solid pharmaceutical compsn valsartan
KRKA 1833464*

Lyophilisation of virosomes
Pevion Biotech 1833465*

Methods for the preparation of a stable pharmaceutical solid
Ranbaxy Laboratories 1833466*

Pharmaceutical compsns for sleep disorders
Collegium Pharmaceutical 1833467*

Tablet formulation for sustained drug-release
Universite de Montreal 1833468*

Pharmaceutical compsns of acid labile substances
Lupin 1833469*

Nanoparticulates for protein drug delivery
Nanomega Medical 1833470*

External patches containing etofenamate
Teikoku Seiyaku 1833471*

Use of certain biphenyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (MS)
Aventis Pharmaceuticals 1833472*

5HT2C receptor modulator compsns and methods of use
Arena Pharmaceuticals 1833473*

Pharmaceutical compsns based on fluorinated sulphamides and sulphinamides
Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; S3F Chimie Societe Chimique de Fabrication de Produits Fluores 1833474*

Use of resolvins to treat gastrointestinal diseases
The Brigham and Women's Hospital 1833475*

Extended release pharmaceutical compsns of celecoxib
Pliva Hrvatska; Pliva - Research and Development 1833476*

Pyrazolo-heteroaryl compounds, useful to treat TNF-alpha and IL-1 mediated diseases
Novartis 1833477*

Use of selected CGRP antagonists in combination with other antimigraine medical substances for the treatment of migraine
Boehringer Ingelheim 1833478*

1-(2-methylpropyl)-1H-imidazo 4,5-C(1,5)naphthyridin-4-amine ethane-sulfonate and 1-(2-methylpropyl)-1H-imidazoy 4,5-C 1,5 naphthyridin-4-amine methanesulphonate
Takeda Pharmaceutical Company 1833479*

Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
Artesian Therapeutics 1833480*

Farnesyl protein transferase inhibitors and methods for treating proliferative diseases
Schering 1833481*

Compounds and therapeutical use thereof
Myriad Genetics 1833482*

Use of selected CGRP antagonists for controlling menopausal hot flashes
Boehringer Ingelheim International 1833483*

Use of CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients
Boehringer Ingelheim International 1833484*

Prevention of thrombotic disorders with active vitamin D compounds or mimics thereof
Novacea 1833485*

Treatment products for animals and means for preparing same
Cardon Pharmaceuticals 1833486*

New use of Gabab receptor agonists
AstraZeneca 1833487*

Casein kinase-2-antisense therapy
Regents of the University of Minnesota; Sloper, Dan; Davis, Alan; Unger, Gretchen; Ahmed, Khalil; Slaton, Joel 1833488*

Glycolipids and analogues thereof as antigens for NK TY cells
The Rockefeller University; Scripps Clinic and Research Foundation 1833489*

RNAI modulation of RSV and therapeutic uses thereof
Alnylam Pharmaceuticals 1833490*

Topical compsns comprising one or more of 44-thiouridine, isomaltitol and uridine
Selectica Pharmaceuticals 1833491*

A new use for very low molecular weight heparins
Opocrin 1833492*

Use of polyethylene oxide for urogenital infection inhibition
Kimberley-Clark Worldwide 1833493*

Regeneration of pancreatic islets by amniotic fluid stem cell therapy
Wake Forest University Health Sciences 1833494*

Dermatologic use of milk proteins
Campina Nederland Holding 1833495*

Treatment of stroke and other acute neurodegenerative disorders using post partum derived cells
Ethicon 1833496*

Bacteriophage compsns
Canagen Life Sciences 1833497*

Oral compsn for enhancing skin properties
Unilever 1833498*

Homeopathic agent for the prophylaxis of diseases caused by parasites
Weineck, Andrea 1833499*

Method to enhance the bone formation activity of BMP by RUNX2 acetylation
Biorunx 1833500*

Laminin receptor binding molecule
Ambrilia Biopharma 1833501*

Pharmaceutical compsn for the treatment of invasive pulmonary aspergillosis
Council of Scientific & Industrial Research 1833502*

Pulmonary surfactant formulations
Discovery Laboratories 1833503*

Sustained delivery of PDGF using self-assembling peptide nanofibres
The Brigham & Women's Hospital 1833504*

Local treatment of bone defects with matrix releasing BMP or PTH
Kuros Biosurgery 1833505*

Use of compsns comprising various tumour-associated antigens as anti-cancer vaccines
Mannkind Corp 1833506*

Compsns for immunizing against mycobacterium
Isis Innovation 1833507*

Porcine reproductive and respiratory syndrome virus strains and compsns
Intervet International 1833508*

Delaying or preventing onset of muscular sclerosis
Biogen Idec 1833509*

Orally deliverable and anti-toxin antibodies and methods for making and using them
Progenics Pharmaceuticals (Nevada) 1833510*

Method of treating brain cancer
Myriad Genetics; Cytovia 1833511*

Optical imaging
GE Healthcare 1833512*

Use of cyanine dyes for the diagnosis of proliferative diseases
Bayer Schering Pharma 1833513*

Phospholipid ether analogues for detecting and treating cancer
Cellectar 1833514*

Trending Articles

You may also like